Context

KKR led a leveraged buyout of Elsan, becoming the majority shareholder with 43% of the capital. CVC Capital Partners, an existing shareholder, reinvested and retained a 22% stake. A French institutional investor pool holding 35% of the capital was assembled alongside KKR and CVC, comprising Téthys Invest (~15%), Ardian (~7%), AXA (~5%), CNP Assurances (via its infrastructure investment activity), and Mérieux Equity Partners. The French pool was deliberately structured to ensure strong domestic institutional backing given the strategic importance of private hospitalisation in France, heightened by the COVID-19 pandemic.

Target

Elsan is the second largest private hospital group in France , operating a broad network of private clinics and hospitals across the French territory. The group was originally built through the merger of two major private hospital platforms, including Vedici, whose co-founders Michel Bodkier and Jérôme Nouzarède had been significant shareholders in Elsan. Elsan operates across a wide range of medical and surgical specialties, serving both privately-funded and Social Security-reimbursed patients. The group is considered a strategically important asset in the French healthcare landscape, particularly in light of the increased strategic significance of private hospitalisation during and after the COVID-19 pandemic. Its scale, national footprint, and positioning as the second largest French private hospital operator made it a highly attractive platform for large-scale private equity investment.